TABLE 6.
Neutralization of HIV-189.6 by MAbs alone or in combinationa
Antibody 2b | ID90 of antibody 1 alone or in combination with antibody 2c
|
|||
---|---|---|---|---|
IgG1 b12 | F(ab′)2 b12 | 2G12 | 2F5 | |
None | 6.25 | 3.1 | 100 | 75 |
IgG1 b12 (1) | 25 | 50 | ||
F(ab′)2 b12 (1) | 50 | 50 | ||
2G12 (50) | 1.25 | NDd | 50 | |
2F5 (10) | 6.25 | ND | 50 |
Neutralization synergy of antibody combinations for HIV-189.6 was assessed by using an alternative approach to determining synergy in which the neutralization dose-response curve of one MAb (antibody 1) was assessed in the presence or absence of a fixed, weakly neutralizing concentration of a second MAb (antibody 2).
The fixed concentration of antibody 2 is indicated in micrograms per milliliter in parenthesis.
ID90s are shown in micrograms of antibody 1 per milliliter alone or in combination with a weakly neutralizing concentration of antibody 2. A decrease in the ID90 of antibody 1 indicates synergy.
ND, not done.